The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found.
It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung ...
Diffuse pulmonary meningiotheliomatosis (DPM) and minute pulmonary menigiothelial-like nodules (MPMNs) are rare pulmonary pathologies often detected incidentally. These lesions are often benign.
As a nonsmoker lung cancer hasn't been a concern of mine, but I recently heard it can affect people who have never smoked. If someone is concerned about lung cancer, what symptoms should they watch ...
SAULTE STE MARIE — MyMichigan Medical Center Sault has begun offering PSMA PET scans, providing men in the eastern Upper Peninsula with an advanced imaging tool to detect prostate cancer. The ...
US fighter jets intercept Russian warplanes off Alaskan coast Illinois governor taken by surprise by Bears' statement on stadium in Indiana Tom Cruise and Brad Pitt trade blows in latest AI slop video ...
Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and effective treatment. Conventional computer-aided ...
The proposed CNN-based system demonstrates the feasibility and robustness of deep learning for automatic lung nodule detection and classification. Despite strong results, the study acknowledges ...
A PSMA PET scan found more recurrent prostate cancer at low PSA levels than a standard scan, helping guide more potentially curative treatment decisions. A newer type of prostate cancer scan called 64 ...
Please provide your email address to receive an email when new articles are posted on . The main element of RevealAI-Lung is the Malignancy Similarity Index (mSI) score. In a study population of 1,530 ...
An artificial intelligence (AI)-powered tool that characterizes lung nodules has earned clearance from the FDA, according to a press release from manufacturer RevealDx. The RevealAI-Lung software ...